Literature DB >> 1762629

Heterogeneity of the genes encoding the major surface glycoprotein of Leishmania donovani.

J R Webb1, L L Button, W R McMaster.   

Abstract

The major surface glycoprotein of Leishmania (GP63) is present on all known species of Leishmania and likely plays an integral role during the infection of macrophages in the mammalian host. To identify regions of GP63 which may be of functional significance, the nucleotide sequence of a gene encoding GP63 of Leishmania donovani was determined and compared to the sequences reported for GP63 genes of Leishmania major and Leishmania chagasi. The GP63 nucleotide and predicted protein sequence was highly conserved among the 3 species despite their diverse geographical distribution. L. donovani GP63 is encoded by a multigene family and the gene locus contains at least 7 tandemly repeated genes and at least 3 genes which are dispersed from the tandem array. In addition, polymerase chain reaction and Southern blot analyses demonstrated that there was size heterogeneity within the pro-peptide coding regions of the multiple GP63 genes of L. donovani and that such genes were expressed concurrently in the promastigote life stage.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1762629     DOI: 10.1016/0166-6851(91)90113-k

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  10 in total

1.  Nonrandom spatial distribution of synonymous substitutions in the GP63 gene from Leishmania.

Authors:  F Alvarez-Valin; J F Tort; G Bernardi
Journal:  Genetics       Date:  2000-08       Impact factor: 4.562

2.  Extrachromosomal genetic complementation of surface metalloproteinase (gp63)-deficient Leishmania increases their binding to macrophages.

Authors:  X Liu; K P Chang
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

3.  gp63 homologues in Trypanosoma cruzi: surface antigens with metalloprotease activity and a possible role in host cell infection.

Authors:  Ileana C Cuevas; Juan J Cazzulo; Daniel O Sánchez
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

4.  Involvement of Leishmania donovani major surface glycoprotein gp63 in promastigote multiplication.

Authors:  Sanjeev Pandey; Phuljhuri Chakraborti; Rakhi Sharma; Santu Bandyopadhyay; Dwijen Sarkar; Samit Adhya
Journal:  J Biosci       Date:  2004-03       Impact factor: 1.826

5.  Cloning and structure-function analysis of the Leishmania donovani kinetoplastid membrane protein-11.

Authors:  A Jardim; S Hanson; B Ullman; W D McCubbin; C M Kay; R W Olafson
Journal:  Biochem J       Date:  1995-01-01       Impact factor: 3.857

6.  Developmental changes in the expression of Leishmania chagasi gp63 and heat shock protein in a human macrophage cell line.

Authors:  J A Streit; J E Donelson; M W Agey; M E Wilson
Journal:  Infect Immun       Date:  1996-05       Impact factor: 3.441

Review 7.  The pathogenicity and virulence of Leishmania - interplay of virulence factors with host defenses.

Authors:  Anand Kumar Gupta; Sonali Das; Mohd Kamran; Sarfaraz Ahmad Ejazi; Nahid Ali
Journal:  Virulence       Date:  2022-12       Impact factor: 5.428

8.  Insights from the analysis of a predicted model of gp63 in Leishmania donovani.

Authors:  Ali Razzazan; Mohammad Reza Saberi; Mahmoud Reza Jaafari
Journal:  Bioinformation       Date:  2008-11-02

9.  Immunogenicity and efficacy of single antigen Gp63, polytope and polytopeHSP70 DNA vaccines against visceral Leishmaniasis in experimental mouse model.

Authors:  Rakhee Sachdeva; Akhil C Banerjea; Nancy Malla; Mohan Lal Dubey
Journal:  PLoS One       Date:  2009-12-02       Impact factor: 3.240

10.  A glycosylphosphatidylinositol (GPI)-negative phenotype produced in Leishmania major by GPI phospholipase C from Trypanosoma brucei: topography of two GPI pathways.

Authors:  K Mensa-Wilmot; J H LeBowitz; K P Chang; A al-Qahtani; B S McGwire; S Tucker; J C Morris
Journal:  J Cell Biol       Date:  1994-03       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.